Apidel is Drug Discovery in Switzerland that focus on pharmaceutical formulation business. Founded in 2011. They cover business area such as developer, pharmaceutical product, pharmaceutical formulation and drug delivery, polymeric vehicle, an internal pipeline, approve pharmaceutical, engage, pharmaceutical partner, joint development, various field, proprietary drug delivery technology, doctor, effective therapeutic product, patient, their prescribed medical treatment.
2011
( 13 years old in 2024 )
Pharmaceutical Formulation
-
The Business Harbour
29 Quai du Mont Blanc
1201 Geneva
Switzerland
Private
developerpharmaceutical productpharmaceutical formulation and drug deliverypolymeric vehiclean internal pipelineapprove pharmaceuticalengagepharmaceutical partnerjoint developmentvarious fieldproprietary drug delivery technologydoctoreffective therapeutic productpatienttheir prescribed medical treatment
* We use standard office opening hours in near Apidel's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Apidel is Drug Discovery business from Switzerland that founded in 2011 (13 years old in 2024), Apidel business is focusing on Pharmaceutical Formulation.
Apidel headquarter office and corporate office address is located in The Business Harbour 29 Quai du Mont Blanc 1201 Geneva Switzerland.
Apidel was founded in Switzerland.
In 2024, Apidel is currently focus on pharmaceutical formulation sector.
Above is snippet of Google Trends for "pharmaceutical formulation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Apidel, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
